[go: up one dir, main page]

HK1054737A1 - 五倍子酸衍生物及其探測內源性凝血的用途 - Google Patents

五倍子酸衍生物及其探測內源性凝血的用途 Download PDF

Info

Publication number
HK1054737A1
HK1054737A1 HK03105405.5A HK03105405A HK1054737A1 HK 1054737 A1 HK1054737 A1 HK 1054737A1 HK 03105405 A HK03105405 A HK 03105405A HK 1054737 A1 HK1054737 A1 HK 1054737A1
Authority
HK
Hong Kong
Prior art keywords
coagulation
exploring
gallic acid
endogenetic
acid derivatives
Prior art date
Application number
HK03105405.5A
Other languages
English (en)
Inventor
Roisin Jean-Paul
Steurs Stephane
Quentin Gerard
Original Assignee
Societe Diagnostica-Stago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe Diagnostica-Stago filed Critical Societe Diagnostica-Stago
Publication of HK1054737A1 publication Critical patent/HK1054737A1/zh

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/50Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/82Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/88Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polyethers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK03105405.5A 2001-03-23 2002-03-22 五倍子酸衍生物及其探測內源性凝血的用途 HK1054737A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR01/03979 2001-03-23
FR0103979A FR2822462B1 (fr) 2001-03-23 2001-03-23 Composes activateurs de la coagulation endogene utilisation pour l'exploration de la coagulation endogene
PCT/FR2002/001020 WO2002076921A1 (fr) 2001-03-23 2002-03-22 Derives de l'acide gallique et utilisation pour l'exploration de la coagulation endogene

Publications (1)

Publication Number Publication Date
HK1054737A1 true HK1054737A1 (zh) 2003-12-12

Family

ID=8861494

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03105405.5A HK1054737A1 (zh) 2001-03-23 2002-03-22 五倍子酸衍生物及其探測內源性凝血的用途

Country Status (15)

Country Link
US (1) US7208266B2 (zh)
EP (1) EP1280758A1 (zh)
JP (1) JP4563648B2 (zh)
KR (1) KR20030005359A (zh)
CN (1) CN100432046C (zh)
AR (1) AR034221A1 (zh)
BR (1) BR0204494A (zh)
CA (1) CA2407779A1 (zh)
FR (1) FR2822462B1 (zh)
HK (1) HK1054737A1 (zh)
HU (1) HUP0302136A3 (zh)
MX (1) MXPA02011565A (zh)
PL (1) PL357449A1 (zh)
RU (1) RU2002131457A (zh)
WO (1) WO2002076921A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05007165A (es) * 2002-12-31 2005-09-21 Nektar Therapeutics Al Corp Reactivos polimericos que comprnden una cetona o un grupo funcional relacionado.
DE102007062323A1 (de) * 2007-12-21 2009-06-25 Siemens Healthcare Diagnostics Products Gmbh Langzeitstabiles Thromboplastin-Reagenz
JP6577778B2 (ja) * 2015-07-30 2019-09-18 シスメックス株式会社 凝固時間の測定方法およびその装置、凝固時間測定用試薬ならびに試薬キット
CN105424945B (zh) * 2015-11-20 2018-05-18 重庆贝羿生物科技有限公司 一种凝血激活检测试剂及其制备方法与用途
KR101651605B1 (ko) * 2015-12-10 2016-08-26 대봉엘에스 주식회사 신규 페놀산류 유도체 화합물, 및 이의 용도
CN108344875B (zh) * 2017-01-22 2021-11-02 上海长岛生物技术有限公司 提高活化部分凝血活酶时间试剂对肝素敏感性的方法及用途
EP3859327A4 (en) 2018-09-25 2022-09-07 Sekisui Medical Co., Ltd. METHOD OF MEASUREMENT OF BLOOD COAGING TIME
CN110824154A (zh) * 2019-10-15 2020-02-21 常熟常江生物技术有限公司 用于血栓弹力图仪的激活剂
CN113679039B (zh) * 2021-05-12 2023-05-09 浙江大学 一种没食子酸聚乙二醇酯蛋白载体增效剂及其制备方法与应用
CN116496186A (zh) * 2023-05-04 2023-07-28 浙江海洋大学 一类水溶性没食子酸衍生物、制备方法及其在水产品抗氧化处理中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565823A (en) * 1976-11-11 1980-04-23 Pilkington Brothers Ltd Coating of glass fibres
JPS60199850A (ja) * 1984-03-26 1985-10-09 Eisai Co Ltd 新規な没食子酸誘導体
DE3544338A1 (de) * 1985-12-14 1987-06-19 Hoechst Ag Peptid-derivate mit inhibitorischer wirkung auf hydroxylierende enzyme, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
US5041558A (en) * 1986-04-11 1991-08-20 Sekisui Kagaku Kogyo Kabushiki Kaisha Accelerator of the activity of hydrolase
US4994192A (en) * 1990-01-16 1991-02-19 Eastman Kodak Company Amine polymers as coagulator accelerators in blood phase separation
US4979471A (en) * 1990-04-09 1990-12-25 Larry Hartshorn Animal confinement chute
JPH05506309A (ja) * 1990-04-17 1993-09-16 アナリティカル・コントロール・システムズ・インコーポレーテッド 凝固アッセイおよび試薬

Also Published As

Publication number Publication date
WO2002076921A1 (fr) 2002-10-03
CA2407779A1 (fr) 2002-10-03
US7208266B2 (en) 2007-04-24
FR2822462B1 (fr) 2005-07-15
US20030157582A1 (en) 2003-08-21
FR2822462A1 (fr) 2002-09-27
CN1460098A (zh) 2003-12-03
EP1280758A1 (fr) 2003-02-05
RU2002131457A (ru) 2004-04-10
JP4563648B2 (ja) 2010-10-13
BR0204494A (pt) 2003-04-08
HUP0302136A3 (en) 2005-12-28
CN100432046C (zh) 2008-11-12
HUP0302136A2 (hu) 2003-09-29
AR034221A1 (es) 2004-02-04
PL357449A1 (en) 2004-07-26
JP2004519507A (ja) 2004-07-02
MXPA02011565A (es) 2004-09-06
KR20030005359A (ko) 2003-01-17

Similar Documents

Publication Publication Date Title
WO2002072851A3 (en) Lentiviral packaging constructs
AU2003302626A1 (en) 1, 2, 5-thiadiazolidin-3-one 1, 1 dioxide derivatives as inhibitors of protein tyrosine phosphatase ptp1b
ZA200309460B (en) Novel Benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl trasferase proteins.
IL183953A (en) Method of reducing oxidant induced damage of a food product, a pharmaceutical or stored blood and novel compounds therefor
WO2005007115A3 (en) Pharmaceutical composition for inhibiting acid secretion
WO2004046308A3 (en) Methods and compositions for the preservation of cells, tissues or organs in the vitreous state
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
WO2006004722A3 (en) Compositions and methods for selectively activating human sirtuins
WO2001049703A3 (en) Substituted sapogenins and their use
HK1054737A1 (zh) 五倍子酸衍生物及其探測內源性凝血的用途
TR200200821T2 (tr) 5-Beta-sapojenin ve pseudosapojenin türevleri ve bunların bunama tedavisinde kullanımı.
WO2003029420A3 (en) Apo-2 ligand variants and uses thereof
WO2001070204A3 (de) Hochselektive inhibitoren des urokinase-plasminogenaktivators
WO2002036145A3 (en) Kahalalide f formulation
MXPA03000471A (es) Transportador de grabacion para almacenar un trabajo digital.
IL154850A0 (en) Polysubstituted imidazopyridine derivatives and pharmaceutical compositions containing the same
WO2001066144A3 (en) Antineoplastic combination comprising an inhibitor of angiogenesis and an inhibitor of dna topoisomerase i enzyme activity
AU2001251655A1 (en) Cytokine uses; compositions; methods
IL154324A0 (en) Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis
WO2004003006A3 (fr) Peptides antimicrobiens pour la conservation des aliments
WO2003039270A1 (fr) Aliments et boissons agissant contre l'obesite
WO2003017817A3 (en) Diagnosis, prevention and treatment of cancer
WO2006085954A3 (en) In vitro reconstitution of ribonucleoprotein complexes, and methods of use therefor
WO2003048106A3 (fr) 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
WO2003018763A3 (en) Modulation of appl expression